ALYSSA FIKES: Open Payments
NPI 1700474624 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,477 in 199 payments from 17 companies in 2025. Trend: 2023 $3,168 · 2024 $3,160 · 2025 $3,477
Food & beverage: $3,477
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 75 | $1,418 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 34 | $420 |
| Madrigal Pharmaceuticals | 12 | $263 |
| Janssen Biotech, Inc. | 16 | $261 |
| Regeneron Healthcare Solutions, Inc. | 7 | $173 |
| QOL Medical, LLC | 6 | $168 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $123 |
| GENZYME CORPORATION | 5 | $122 |
| Ardelyx, Inc. | 6 | $118 |
| Phathom Pharmaceuticals, Inc. | 15 | $114 |
Products named: RINVOQ, XIFAXAN, DUPIXENT, REZDIFFRA, TREMFYA, SKYRIZI, LINZESS, Sucraid.
Industry payments across AL — which companies pay providers there.
